Fusion Pharmaceuticals Inc

NASDAQ:FUSN  
3.86
+0.15 (+4.04%)
Earnings Announcements

Fusion Pharmaceuticals Q1 Loss Per Share $0.46

Published: 05/10/2022 11:15 GMT
Fusion Pharmaceuticals Inc (FUSN) - Q1 Loss per Share $0.46.
As of March 31, 2022, Fusion Held Cash, Cash Equivalents and Investments of $206.7 Million.
Q1 Earnings per Share View $-0.48 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0.18 Million
Adjusted EPS is expected to be -$0.51

Next Quarter Revenue Guidance is expected to be $0.17 Million
Next Quarter EPS Guidance is expected to be -$0.53

More details on our Analysts Page.